申请人:Shaman Pharmaceuticals, Inc.
公开号:US05648354A1
公开(公告)日:1997-07-15
Novel 1,2-dithiin compounds useful as antifungal or anti-infective agents, as well as methods for their use as such, are described. The 1,2-dithiin compounds are particularly effective in treating infections, especially those caused by Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, Candida krusei, Candida parapsilosis, Candida tropicalis, Trichophyton rubrum, Epidermophyton species, Microsporum species, Sporothrix species, Blastomyces dermatitidis, Coccidiodes immiitis, Histoplasma capsulatum, Herpes virus, Influenza virus, Cytomegalovirus, human immunodeficiency virus, retrovirus, Adenovirus, Papillomavirus, Paravirus, Arenavirus, Bunyavirus, Coronavirus, Paramyxovirus, Picornavirus, Rhabdovirus, Togavirus, Hepadnavirus, Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Enterobacter aerogenes, Klebsiella pneumoniae, Staphylococcus epidermis, Zanthomonus maltrophilia, Acinetobacter, Enterobacter cloacae, Serratia marscens, Listeria, Monocytogenes, Enterococcus faecalis, Streptococcus pyogenes; Streptococcus pneumonia, Viridans streptococci, Haemophilus influenzae, Proteus mirabills, Proteus vulgaris and Bacterioides fragilis.
本发明描述了作为抗真菌或抗感染剂有用的Novel 1,2-二噻吩化合物,以及它们作为此类药物使用的方法。1,2-二噻吩化合物在治疗感染方面特别有效,尤其是由白色念珠菌、新生隐球菌、烟曲霉、克鲁茨白色念珠菌、副溶血性白色念珠菌、热带白色念珠菌、红色毛癣菌、表皮癣菌属、皮癣菌属、丝孢菌属、皮肤芽胞菌、球孢子菌、组织胞浆菌、疱疹病毒、流感病毒、巨细胞病毒、人类免疫缺陷病毒、逆转录病毒、腺病毒、乳头状瘤病毒、副黏病毒、汉坦病毒、布尼病毒、冠状病毒、副粘病毒、狂犬病毒、拟病毒、乙肝病毒、金黄色葡萄球菌、肠球菌、大肠杆菌、铜绿假单胞菌、肺炎克雷伯菌、表皮葡萄球菌、麦芽芽孢杆菌、不动杆菌、肠杆菌、马氏杆菌、李斯特菌、嗜单核细胞增多症杆菌、肺炎链球菌、绿色链球菌、流感嗜血杆菌、奇异变形杆菌和脆弱类杆菌引起的感染方面特别有效。